影响HIV感染者与非感染者SARS-CoV-2疫苗接种的社会人口学因素:瑞典全国队列研究启示
瑞典全国队列研究纳入7233名非脆弱HIV感染者、435名临床脆弱HIV感染者和8168340名非感染者,评估2020年12月27日至2023年2月23日1-5剂SARS-CoV-2疫苗接种率。调整后非脆弱HIV感染者3剂接种率较高(adjRR 1.17,95%CI 1.15-1.19),但≥65岁HIV感染者接种率较低(第5剂adjRR 0.90,95%CI 0.85-0.96),移民接种率低于瑞典出生者。
要点
- 调整后非脆弱HIV感染者3剂接种率高于非感染者(adjRR 1.17,95%CI 1.15-1.19)。
- ≥65岁HIV感染者较非感染者≥65岁者更少接种3剂及以上(第5剂adjRR 0.90,95%CI 0.85-0.96)。
- 移民无论HIV状态接种率均较低,HIV感染者移民低于瑞典出生HIV感染者。
核心结论
- 移民无论HIV状态疫苗接种率均较低,与既往研究一致;最令人担忧的是≥65岁HIV感染者疫苗接种率较低。
- 该全国性研究强调需要针对HIV状态和人口学因素的针对性疫苗接种策略和干预。
研究设计与样本
- 瑞典全国性研究,纳入1930-2003年出生个体,评估2020年12月27日至2023年2月23日期间1-5剂SARS-CoV-2疫苗接种率。
- HIV感染者按优先分组分为临床脆弱组(CD4+ T细胞<50cells/μL、近期机会性疾病,或CD4+ T细胞<200且HIV-RNA>200copies/mL)和非优先组(非脆弱HIV感染者)。
- 采用改良Poisson回归估计1-5剂相对风险(adjRR),调整社会人口学、SARS-CoV-2感染和合并症。
- 纳入7233名非脆弱HIV感染者、435名临床脆弱HIV感染者和8168340名非感染者。
主要发现
- 未调整3剂接种率在两组HIV感染者中均低于非感染者,调整后非脆弱HIV感染者接种率较高(adjRR 1.17,95%CI 1.15-1.19),临床脆弱组趋势相似。
- 出生国家与HIV状态存在交互作用(p < 0.001)。
- 移民HIV感染者3剂接种率高于移民非感染者,但低于瑞典出生HIV感染者。
- ≥65岁人群中,HIV感染者较非感染者≥65岁者更少接种3剂及以上(第5剂adjRR 0.90,95%CI 0.85-0.96)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There is limited data regarding SARS-CoV-2 vaccine uptake in people with HIV (PWH) compared to people without HIV (PWoH). METHODS: Swedish nationwide study of individuals born 1930-2003, assessing SARS-CoV-2 vaccine uptake of 1-5 doses by HIV-status from first SARS-CoV-2 vaccination (2020-12-27) until 2023-02-23. PWH were categorized by prioritization: clinically vulnerable (CD4+ T-cells <50cells/μL, recent opportunistic disease, or CD4+ T-cells <200 in combination with detectable HIV-RNA > 200copies/mL), and not prioritized (non-vulnerable PWH). Relative risks (adjRR) for doses 1-5 were estimated using modified Poisson regression, adjusted for sociodemographics, SARS-CoV-2 infections, and comorbidities. RESULTS: 7233 non-vulnerable PWH, 435 clinically vulnerable PWH, and 8,168,340 PWoH were included. While unadjusted 3-dose uptake was lower in both PWH groups compared to PWoH, adjusted analysis showed higher uptake in non-vulnerable PWH (adjRR1.17, 95 % CI 1.15-1.19), with similar trends in clinically vulnerable. An interaction between country of birth and HIV-status was identified (p < 0.001). Migrants with HIV had higher 3-dose uptake vs. migrants without HIV, but were less likely vaccinated than Swedish-born with HIV. Among people ≥65 years old, PWH were less likely to receive 3 or more doses compared to PWoH ≥65 years (dose 5: adjRR 0.90, 95 % CI 0.85-0.96). CONCLUSIONS: We found lower vaccination uptake in migrants, irrespective of HIV-status, consistent with previous studies. Most concerningly we identified a lower vaccine uptake among people with HIV who were 65 years or older. This nationwide study highlights the need for targeted vaccination strategies and interventions that address both HIV-status and demographic factors.
引用
- Killander Möller I, Hedberg P, Wagner P, et al. Sociodemographic factors influencing SARS-CoV-2 vaccination uptake in people with and without HIV: Insights from a Swedish Nationwide cohort. Vaccine. 2025. PMID: 40782463. doi:10.1016/j.vaccine.2025.127580
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。